Muhammad

University of Birmingham and Acticor Biotech Gain Regulatory Approval for Groundbreaking LIBERATE Clinical Study

University of Birmingham and Acticor Biotech Gain Regulatory Approval for Groundbreaking LIBERATE Clinical Study

Birmingham - September 9, 2023: In a momentous development for cardiovascular medicine, the University of Birmingham and Acticor Biotech have received full regulatory approval for the LIBERATE clinical study. This study marks a significant stride towards potential breakthroughs in the treatment of heart attacks, using the novel antithrombotic drug, glenzocimab.
Pharmaceuticals
Muhammad 2 min read